Position Statement on Out of Network Restriction of Psychiatrists

Position Statement on Out of Network Restriction of Psychiatrists

Position Statement on Level of Care Criteria for Acute Psychiatric Treatment

Position Statement on Level of Care Criteria for Acute Psychiatric Treatment

Position Statement on Carve Outs and Discrimination

Position Statement on Carve Outs and Discrimination

Consensus statement on "Managing the risks of repetitive transcranial stimulation"

In response to the changing managed care environment, the APA Committee on Managed Care established a subcommittee to document the changes in managed care and to begin the process of thinking about alternative healthcare financing systems. The Committee undertook writing a resource document for APA members to identify and describe the changes that are occurring in the healthcare sector and to prepare them for changes that may occur so that psychiatry can be proactive in meeting these challenges

Position Statement on Second Generation Antipsychotic Medications

Position Statement on Second Generation Antipsychotic Medications

Position Statement on Ensuring Access to, and Appropriate Utilization of, Psychiatric Services for the Elderly

Position Statement on Ensuring Access to, and Appropriate Utilization of, Psychiatric Services for the Elderly

Position Statement on Discriminatory Disability Insurance Coverage

Position Statement on Discriminatory Disability Insurance Coverage

Position Statement on Banning of Pharmacy Benefit Management Policies that Require the Provision of Dangerous Quantities of Medications

Position Statement on Banning of Pharmacy Benefit Management Policies that Require the Provision of Dangerous Quantities of Medications

Position Statement on Prior Authorizations for Psychotropic Medications

Position Statement on Prior Authorizations for Psychotropic Medications

Safe Consumption Facilities

In 2019, there were nearly 72,000 U.S. overdose deaths, a new record high. Most of these overdose deaths involved opioids, with rising involvement of fentanyl and fentanyl analogues, which are increasingly found in street heroin and other opioids and often without the knowledge of the user. Even more concerning, it appears that the coronavirus pandemic is further worsening the overdose crisis.1 In the context of this ongoing crisis, psychiatrists must be aware of the full range of policy, organi

Education and Training for Substance Use Disorders

Current training of physicians in the recognition and treatment of substance use disorders (SUD) is inadequate to meet the needs of such a diverse and growing population of patients. Medical schools, physician training (residency) programs, and continuing education programs for physicians in practice, provide limited training in the treatment of SUDs. The scope of training on SUDs is disproportionate to the population health need to address these problems, and many with SUDs go undiagnosed and u

The Management of Depression during Pregnancy: A Report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists

Objective—To address the maternal and neonatal risks of both depression and antidepressant exposure and develop algorithms for periconceptional and antenatal management. Method—Representatives from the American Psychiatric Association, the American College of Obstetricians and Gynecologists and a consulting developmental pediatrician collaborated to review English language articles on fetal and neonatal outcomes associated with depression and antidepressant treatment during childbearing. Ar